American Century Companies’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMRX
S
DA
American Century Companies's IMRX Position: Q2 2026 in Review
American Century Companies increased its Immuneering (IMRX) stake by 74% in Q2 2026, buying an estimated $128K and bringing the position to 59,558 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #2706.
American Century Companies first reported a position in IMRX in Q3 2023 and has held it in 5 quarters since. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.
- American Century Companies held 59,558 shares of Immuneering worth $297K as of Q2 2026.
- American Century Companies bought 25,334 Immuneering shares in Q2 2026, an estimated $128K.
- Immuneering made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2706 holding.
- American Century Companies first reported a position in Immuneering in Q3 2023 and has held it in 5 quarters since.
- 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.